Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference40 articles.
1. Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969–2016) (www.seer.cancer.gov/popdata), National Cancer Institute, DCCPS, Surveillance Research Program, released December 2017.
2. Cohen N, Strong V, Janjigian Y. Checkpoint blockade in esophagogastric cancer. J Surg Oncol. 2018;118(1):77–85. https://doi.org/10.1002/jso.25116.
3. Long J, Lin J, Wang A, Wu L, Zheng Y, Yang X, et al. PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. J Hematol Oncol. 2017;10(1):146. https://doi.org/10.1186/s13045-017-0511-2.
4. Murphy A, Kelly RJ. Immunotherapy in upper GI malignancies. Curr Treat Options in Oncol. 2015;16:20. https://doi.org/10.1007/s11864-015-0336-6.
5. Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97. https://doi.org/10.1016/S0140-6736(10)61121-X.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献